文献速递消化道肿瘤与早癌

空肠弯曲菌通过细胞致死膨胀毒素的作用促进结直肠肿瘤发生

Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.
PubMed 文献 · Gut · 2018-10-30

研究在无菌ApcMin/+小鼠中定植产细胞致死膨胀毒素(CDT)的空肠弯曲菌81-176,发现其促进结直肠肿瘤发生且依赖cdtB;突变cdtB可减弱肿瘤发生与DNA损伤反应;雷帕霉素可减弱其致瘤能力。

要点

  • 产CDT的空肠弯曲菌81-176使无菌ApcMin/+小鼠肿瘤更多更大。
  • cdtB突变株减弱体内肿瘤发生及细胞与肠类器官DNA损伤反应。
  • 雷帕霉素可减弱产CDT空肠弯曲菌的致瘤能力。

核心结论

  • 人临床分离株空肠弯曲菌81-176促进结直肠癌并诱导微生物组成和转录组反应改变,该过程依赖CDT产生。

研究设计与样本

  • 使用喂饲1%葡聚糖硫酸钠的无菌ApcMin/+小鼠测试产CDT空肠弯曲菌的致瘤潜力。
  • 细胞和肠类器官暴露于细菌裂解物,通过γH2AX免疫荧光、彗星试验和细胞周期试验测定DNA损伤能力。
  • 进行结肠RNA测序和粪便16S rDNA测序以检查产CDT空肠弯曲菌、肠道微生物组与宿主在肿瘤发生中的相互作用。
  • 给予雷帕霉素以研究预防产CDT空肠弯曲菌诱导的肿瘤发生。

主要发现

  • 定植人临床分离株空肠弯曲菌81-176的无菌ApcMin/+小鼠与未感染小鼠相比,发生显著更多和更大的肿瘤。
  • cdtB亚基突变的空肠弯曲菌mutcdtB减弱了体内空肠弯曲菌诱导的肿瘤发生,并减少细胞和肠类器官中的DNA损伤反应。
  • 空肠弯曲菌感染诱导数百个结肠基因表达,其中22个基因依赖cdtB的存在。
  • 宏转录组数据显示,空肠弯曲菌感染组与mutcdtB组的微生物基因表达谱显著不同,16S rDNA测序显示微生物群落不同。
  • 雷帕霉素可减弱空肠弯曲菌的致瘤能力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Campylobacter jejuni produces a genotoxin, cytolethal distending toxin (CDT), which has DNAse activity and causes DNA double-strand breaks. Although C. jejuni infection has been shown to promote intestinal inflammation, the impact of this bacterium on carcinogenesis has never been examined. DESIGN: Germ-free (GF) ApcMin/+ mice, fed with 1% dextran sulfate sodium, were used to test tumorigenesis potential of CDT-producing C. jejuni. Cells and enteroids were exposed to bacterial lysates to determine DNA damage capacity via γH2AX immunofluorescence, comet assay and cell cycle assay. To examine the interplay of CDT-producing C. jejuni, gut microbiome and host in tumorigenesis, colonic RNA-sequencing and faecal 16S rDNA sequencing were performed. Rapamycin was administrated to investigate the prevention of CDT-producing C. jejuni-induced tumorigenesis. RESULTS: GF ApcMin/+ mice colonised with human clinical isolate C. jejuni81-176 developed significantly more and larger tumours when compared with uninfected mice. C. jejuni with a mutated cdtB subunit, mutcdtB, attenuated C. jejuni-induced tumorigenesis in vivo and decreased DNA damage response in cells and enteroids. C. jejuni infection induced expression of hundreds of colonic genes, with 22 genes dependent on the presence of cdtB. The C. jejuni-infected group had a significantly different microbial gene expression profile compared with the mutcdtB group as shown by metatranscriptomic data, and different microbial communities as measured by 16S rDNA sequencing. Finally, rapamycin could diminish the tumorigenic capability of C. jejuni. CONCLUSION: Human clinical isolate C. jejuni 81-176 promotes colorectal cancer and induces changes in microbial composition and transcriptomic responses, a process dependent on CDT production.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. He Z, Gharaibeh RZ, Newsome RC, et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut. 2018. PMID: 30377189. doi:10.1136/gutjnl-2018-317200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。